
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
KIAA0664 CRISPR/Cas9 KO Plasmid (h) | sc-407383 | 20 µg | $397.00 |
CLUH (also known as KIAA0664) encodes a cytosolic RNA-binding protein that couples mitochondrial biogenesis with spatial organization of mitochondria by regulating the stability, localization, and translation of nuclear-encoded mRNAs for mitochondrial proteins. It contributes to oxidative phosphorylation capacity and cellular energy homeostasis, influencing processes such as stress responses and metabolic adaptation through control of mitochondria-associated gene expression programs. Disruption of CLUH-linked mitochondrial regulation can perturb respiratory function, alter mitochondrial distribution, and impact pathways governing cell growth and survival. Accordingly, CLUH is relevant to research on mitochondrial dysfunction and metabolism-associated disease mechanisms, including contexts where altered bioenergetics and organelle dynamics are hallmarks.
KIAA0664 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CLUH gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CLUH together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CLUH open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish KIAA0664 protein expression.
This CRISPR knockout system enables efficient generation of CLUH-deficient cell models for investigation of KIAA0664 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.